# Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)

> **NCT00495651** · PHASE3 · COMPLETED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 2073 (actual)

## Conditions studied

- HIV Infections
- Tuberculosis

## Interventions

- **DRUG:** Antiretroviral medications
- **DRUG:** Antiretroviral medications+Isoniazid prophylaxis
- **DRUG:** Antiretroviral medications
- **DRUG:** Antiretroviral medications+Isoniazid prophylaxis

## Key facts

- **NCT ID:** NCT00495651
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 2073 (ACTUAL)
- **Last updated:** 2015-06-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00495651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00495651, "Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00495651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*